KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nutanix (NTNX) Cash & Equivalents (2016 - 2026)

Nutanix (NTNX) has disclosed Cash & Equivalents for 12 consecutive years, with $603.4 million as the latest value for Q1 2026.

  • Quarterly Cash & Equivalents fell 43.72% to $603.4 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $603.4 million through Jan 2026, down 43.72% year-over-year, with the annual reading at $769.5 million for FY2025, 17.36% up from the prior year.
  • Cash & Equivalents for Q1 2026 was $603.4 million at Nutanix, down from $780.4 million in the prior quarter.
  • The five-year high for Cash & Equivalents was $1.1 billion in Q1 2025, with the low at $386.7 million in Q2 2022.
  • Average Cash & Equivalents over 5 years is $606.7 million, with a median of $600.2 million recorded in 2024.
  • The sharpest move saw Cash & Equivalents surged 78.65% in 2025, then plummeted 43.72% in 2026.
  • Over 5 years, Cash & Equivalents stood at $480.6 million in 2022, then grew by 27.43% to $612.5 million in 2023, then increased by 17.0% to $716.6 million in 2024, then increased by 8.91% to $780.4 million in 2025, then decreased by 22.68% to $603.4 million in 2026.
  • According to Business Quant data, Cash & Equivalents over the past three periods came in at $603.4 million, $780.4 million, and $769.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.